Dr. Dimitrios Iliopoulos is a world renown expert in the field of artificial intelligence, drug discovery and development. He started his academic career at Harvard Medical School where he was an Assistant Professor of Microbiology & Immunology. Later, he was a tenured Associate Professor of Medicine at UCLA School of Medicine and Founder & Director of the UCLA Center for Systems Biomedicine funded by the Eli & Edythe Broad Foundation. He has received several national and international awards from NIH, the Sidney Kimmel Foundation and the Leona & Harry Helmsley Foundation for the identification of novel genes and development of drugs for patients with autoimmune diseases and cancer. This year he was named in Stanford’s list of the top 2% of scientists in the world. Currently, Dr. Dimitrios Iliopoulos is the CEO and co-founder of Athos Therapeutics Inc, an AI software and clinical stage biotech company pioneering the development of precision therapeutics for patients with autoimmune diseases.